Literature DB >> 20865787

HAX1 deficiency: impact on lymphopoiesis and B-cell development.

Doris Peckl-Schmid1, Susanne Wolkerstorfer, Sebastian Königsberger, Gertrude Achatz-Straussberger, Stefan Feichtner, Elisabeth Schwaiger, Nadja Zaborsky, Michael Huemer, Iris K Gratz, Roger Schibli, Marinus Lamers, Reto Crameri, Katrin Moser, Elke O Luger, Gernot Achatz.   

Abstract

HAX1 was originally described as HS1-associated protein with a suggested function in receptor-mediated apoptotic and proliferative responses of lymphoid cells. Recent publications refer to a complex and multifunctional role of this protein. To investigate the in vivo function of HAX1 (HS1-associated protein X1) in B cells, we generated a Hax1-deficient mouse strain. Targeted deletion of Hax1 resulted in premature death around the age of 12 wk accompanied by a severe reduction of lymphocytes in spleen, thymus and bone marrow. In the bone marrow, all B-cell populations were lost comparably. In the spleen, B220(+) cells were reduced by almost 70%. However, as investigated by adoptive transfer experiments, this impairment is not exclusively B-cell intrinsic and we hypothesize that a HAX1-deficient environment cannot sufficiently provide the essential factors for proper lymphocyte development, trafficking and survival. Hax1(-/-) B cells show a significantly reduced expression of CXCR4, which might have an influence on the observed defects in B-cell development.
Copyright © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20865787     DOI: 10.1002/eji.200940221

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  The design and optimization of RNA trans-splicing molecules for skin cancer therapy.

Authors:  Christina Gruber; Ulrich Koller; Eva M Murauer; Stefan Hainzl; Clemens Hüttner; Thomas Kocher; Andrew P South; Helmut Hintner; Johann W Bauer
Journal:  Mol Oncol       Date:  2013-08-19       Impact factor: 6.603

2.  Gene correction of HAX1 reversed Kostmann disease phenotype in patient-specific induced pluripotent stem cells.

Authors:  Erik Pittermann; Nico Lachmann; Glenn MacLean; Stephan Emmrich; Mania Ackermann; Gudrun Göhring; Brigitte Schlegelberger; Karl Welte; Axel Schambach; Dirk Heckl; Stuart H Orkin; Tobias Cantz; Jan-Henning Klusmann
Journal:  Blood Adv       Date:  2017-06-02

3.  Disruption of the PRKCD-FBXO25-HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis.

Authors:  Ursula Baumann; Vanesa Fernández-Sáiz; Martina Rudelius; Simone Lemeer; Roland Rad; Anna-Maria Knorn; Jolanta Slawska; Katharina Engel; Irmela Jeremias; Zhoulei Li; Viktoriya Tomiatti; Anna-Lena Illert; Bianca-Sabrina Targosz; Martin Braun; Sven Perner; Michael Leitges; Wolfram Klapper; Martin Dreyling; Cornelius Miething; Georg Lenz; Andreas Rosenwald; Christian Peschel; Ulrich Keller; Bernhard Kuster; Florian Bassermann
Journal:  Nat Med       Date:  2014-11-24       Impact factor: 53.440

4.  The histone chaperone Spt6 is required for activation-induced cytidine deaminase target determination through H3K4me3 regulation.

Authors:  Nasim A Begum; Andre Stanlie; Mikiyo Nakata; Hideo Akiyama; Tasuku Honjo
Journal:  J Biol Chem       Date:  2012-07-26       Impact factor: 5.157

Review 5.  Kostmann's Disease and HCLS1-Associated Protein X-1 (HAX1).

Authors:  Christoph Klein
Journal:  J Clin Immunol       Date:  2016-12-10       Impact factor: 8.317

6.  HAX1 regulates E3 ubiquitin ligase activity of cIAPs by promoting their dimerization.

Authors:  Jin Sun Choi; Byoung Chul Park; Seung Wook Chi; Kwang-Hee Bae; Sunhong Kim; Sayeon Cho; Woo-Chan Son; Pyung Keun Myung; Jeong-Hoon Kim; Sung Goo Park
Journal:  Oncotarget       Date:  2014-10-30

7.  Identification and characterization of OSTL (RNF217) encoding a RING-IBR-RING protein adjacent to a translocation breakpoint involving ETV6 in childhood ALL.

Authors:  Luciana M Fontanari Krause; Anna Sophia Japp; Alexandre Krause; Jana Mooster; Martin Chopra; Markus Müschen; Stefan K Bohlander
Journal:  Sci Rep       Date:  2014-10-09       Impact factor: 4.379

8.  HAX1 deletion impairs BCR internalization and leads to delayed BCR-mediated apoptosis.

Authors:  Susanne Wolkerstorfer; Elisabeth Schwaiger; Mark Rinnerthaler; Iris Karina Gratz; Thomas Zoegg; Hans Brandstetter; Gertrude Achatz-Straussberger
Journal:  Cell Mol Immunol       Date:  2015-04-13       Impact factor: 11.530

Review 9.  B Cell Intrinsic Mechanisms Constraining IgE Memory.

Authors:  Brice Laffleur; Orianne Debeaupuis; Zeinab Dalloul; Michel Cogné
Journal:  Front Immunol       Date:  2017-11-13       Impact factor: 7.561

10.  The interactome of multifunctional HAX1 protein suggests its role in the regulation of energy metabolism, de-aggregation, cytoskeleton organization and RNA-processing.

Authors:  Maciej Wakula; Anna Balcerak; Tymon Rubel; Mateusz Chmielarczyk; Ryszard Konopinski; Filip Lyczek; Ewa A Grzybowska
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.